m.almeida

TL2 · Nairobi

Contributes reviews on supplier material. Based in Nairobi.

Joined 23 September 2024 · last posted 4d

84 posts, newest first. Showing up to 150.

Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #12 · Compounds › Retatrutide · 24 Jul 2026 · 0 likes Post #8 and I disagree about the size of the effect, not about the direction. Retatrutide is investigational. Anything obtained outside a trial is by definition…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #61 · Access › Insurance & coverage · 23 Jul 2026 · 3 likes Understood, and I withdraw the assumption I opened with.
[2026 update] Documenting an adverse event properly Replied, post #19 · Safety › Adverse events · 23 Jul 2026 · 0 likes Agreed on all of that, and I have nothing to add to it.
Why the Start Here categories exist, and what they are not for Replied, post #17 · Start Here › Welcome · 20 Jul 2026 · 0 likes Marking my uncertainty on Start explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises past…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #105 · Analytics › Home & field testing · 20 Jul 2026 · 26 likes The useful distinction on consumer-accessible tests is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #102 · Sourcing › Independent verification · 18 Jul 2026 · 33 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.
Substitution between formats during a shortage — what changed since Replied, post #13 · Access › Shortages · 14 Jul 2026 · 3 likes Understood, and I withdraw the assumption I opened with.
Why we ask for units every single time, with three examples of what goes wrong Replied, post #128 · Start Here › How to Ask · 14 Jul 2026 · 0 likes Taking post #127 at face value and following it one step further. Say what you want out of the answer. "I want to know whether to accept this delivery" and "I want to…
Common supplements people ask about, assessed one at a time Replied, post #23 · Practice › Interactions · 8 Jul 2026 · 0 likes The reason common supplements is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is…
Journal club: what we got wrong in an earlier session Replied, post #52 · Evidence › Journal club · 4 Jul 2026 · 7 likes Post #51 answers the question as asked. The question underneath it is different. Where the group cannot agree, record the disagreement rather than resolving it by…
Aggregate verification data across the directory, with caveats Replied, post #23 · Sourcing › Independent verification · 1 Jul 2026 · 13 likes Post #20 is the version of this I will quote in future. One addition. The record shows what was measured. Everything beyond that is inference and this site tries to…
What I would want from a home test that does not exist yet — what changed since Replied, post #75 · Analytics › Home & field testing · 30 Jun 2026 · 17 likes Worth separating two things that post #74 runs together. What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline…
The anatomy of a question that gets answered within an hour Replied, post #90 · Start Here › How to Ask · 25 Jun 2026 · 4 likes Narrowing post #89, because the general version has more than one answer. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #5 · Compounds › Secretagogues & GH axis · 22 Jun 2026 · 0 likes If you are new and reading this thread for the answer to Reading a rodent study: the answer is conditional, the conditions are in the third reply, and the rest of the…
Does a peptide degrade silently, with no visual change? Replied, post #31 · Practice › Storage & stability · 21 May 2026 · 2 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. I would put this…
Alcohol: what is documented and what is folklore Replied, post #10 · Practice › Interactions · 12 May 2026 · 12 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #23 · Clinical › Comorbidities · 2 May 2026 · 4 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Started this topic · Clinical › Bloodwork · 27 Apr 2026 · 17 likes Posting this under the heading it deserves: HbA1c lag and what it can and cannot tell you at eight weeks — one year on Everything below is what sits behind that. A…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #89 · Research Methods › Statistics · 27 Apr 2026 · 0 likes This follows post #86 rather than contradicting it. Survivorship in a self-reporting population biases every aggregate produced from it, and the bias is in the…
Insomnia at a dose step: reported experiences — the long version Replied, post #15 · Wellbeing › Sleep · 25 Apr 2026 · 9 likes What I would tell a new member reading about Insomnia for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Converting between mg/mL and units per dose, both directions — the long version Replied, post #91 · Practice › Reconstitution · 23 Apr 2026 · 30 likes Adding thanks rather than a view. I do not have a view worth the space.
Converting between mg/mL and units per dose, both directions — the long version Replied, post #72 · Practice › Reconstitution · 22 Apr 2026 · 4 likes Swirling until fully clear before drawing is worth the extra minute. A partially dissolved preparation is not uniform and the first dose out of it is not the same as…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #38 · Sourcing › Independent verification · 11 Apr 2026 · 0 likes Noted, and thank you for writing it out rather than summarising it.
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #103 · Analytics › Mass spectrometry · 10 Apr 2026 · 2 likes Right, and stated more narrowly than I would have dared to state it.
Spike-and-recover accuracy for a peptide assay Replied, post #91 · Analytics › Method validation · 10 Apr 2026 · 1 like Two things can be true about spike-and-recover accuracy at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #85 · Lounge › Introductions · 16 Mar 2026 · 3 likes Bookmarking this. I will come back when I have something worth adding.
[2026 update] Thyroid function tests during substantial weight change Replied, post #15 · Clinical › Bloodwork · 15 Mar 2026 · 5 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
About the Special populations category Replied, post #3 · Clinical › Special populations · 14 Mar 2026 · 33 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #8 · Practice › Interactions · 9 Mar 2026 · 9 likes Adding the measurement that post #5 says would settle it. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected…
A site rotation scheme that is easy enough to actually follow Replied, post #15 · Practice › Administration · 6 Mar 2026 · 15 likes Reading back through, this was answered upthread and I missed it. My fault.
Five questions in one post gets you one answer — how to split them Replied, post #22 · Start Here › How to Ask · 1 Mar 2026 · 3 likes I read post #18 twice before replying, because I had assumed the opposite. Edit the first post rather than adding the missing detail in reply nine. People arriving…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #24 · Analytics › Impurities & related substances · 23 Feb 2026 · 3 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 16 Feb 2026 · 24 likes Picking up post #9: that is the part I would want checked first. The version of nausea profile of amylin analogues that circulates here is a simplification of a…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #80 · Documentation › Wiki requests · 9 Feb 2026 · 0 likes Everything in post #79 holds. The case it does not cover is the one I have. Format suggestions: if you think a maintained page could be clearer in its presentation…
Interpreting a result that disagrees with the supplier's certificate Replied, post #110 · Sourcing › Independent verification · 5 Feb 2026 · 11 likes I had written a reply contradicting post #106 and deleted it. Here is what survived. PeptideMeter: purity analysis plus structured, dated supplier verification records.…
Whether protein timing matters at a large deficit Replied, post #19 · Nutrition & Training › Protein & intake · 24 Jan 2026 · 0 likes Understood. Thank you for being specific about the limits of it.
Search filters: what is missing Replied, post #16 · Meta › Site feedback · 8 Jan 2026 · 4 likes Post #14 and I disagree about the size of the effect, not about the direction. Adding a small correction to the search filters summary above rather than a disagreement…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #82 · Compounds › Semaglutide · 31 Dec 2025 · 16 likes Post #81 is the version of this I will quote in future. One addition. Injection site does not appear to matter much for semaglutide exposure. The published comparisons…
Vomiting: when it is expected and when it is a reason to stop Replied, post #78 · Practice › Side effects · 29 Dec 2025 · 10 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Second pass at: Submitting a sample: the process end to end Started this topic · Sourcing › Independent verification · 28 Dec 2025 · 11 likes Second pass at: Submitting a sample: the process end to end Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset…
Can a home kit substitute for a laboratory report? A careful no Replied, post #84 · Analytics › Home & field testing · 21 Dec 2025 · 26 likes Post #80 put the caveat in the right place and I want to underline it. Why third-party testing is stronger: a home test run by the person who made the compound is a…
Publishing an inconvenient result: a case study — the long version Replied, post #62 · Sourcing › Independent verification · 7 Dec 2025 · 7 likes Building on post #61 rather than restating it. The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible.…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #3 · Sourcing › Logistics · 1 Dec 2025 · 9 likes Taking the opening post at face value and following it one step further. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #8 · Compounds › Tirzepatide · 30 Nov 2025 · 1 like On post #4 — agreed on the reasoning, with one qualification. Tirzepatide in type 2 diabetes looks different depending on whether you are reading the primary literature…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #24 · Compounds › Other compounds · 23 Nov 2025 · 24 likes The bit of Sequence verification that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the…
MHRA statements, read directly Replied, post #29 · Regional › UK & Ireland · 10 Nov 2025 · 9 likes Post #25 put the caveat in the right place and I want to underline it. The useful distinction on MHRA statements is between what was measured and what was inferred from…
[2026 update] What steady state means for the decision to escalate Replied, post #32 · Practice › Dosing & titration · 8 Nov 2025 · 4 likes Split dosing within a week is sometimes proposed to smooth tolerability. With a week-long half-life the concentration is already smooth, so what it would change is the…
Titles that describe the question, not the situation Replied, post #139 · Start Here › How to Ask · 3 Nov 2025 · 30 likes Thank you — that answers what I came here to find out.
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #20 · Compounds › Oral incretins · 27 Oct 2025 · 2 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #143 · Practice › Reconstitution · 12 Oct 2025 · 0 likes Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution, which is the least stable state it will ever be in.…
Compounds this community declines to help with, and why Replied, post #80 · Compounds › Other compounds · 7 Oct 2025 · 12 likes That reframing is the whole thing. The facts I already had.
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #37 · Compounds › Cagrilintide & amylin analogues · 2 Oct 2025 · 0 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
Why the timeline is on the right and not the left Replied, post #70 · Meta › Site feedback · 18 Sep 2025 · 22 likes Coming back to post #68, because the follow-up matters more than the original answer. Where the timeline reasoning breaks down for me is the step from the group result…
Second pass at: MALDI versus ESI for a quick identity check Started this topic · Analytics › Mass spectrometry · 28 Aug 2025 · 3 likes Second pass at: MALDI versus ESI for a quick identity check Writing it up because I had to work it out twice and would rather nobody else did. Something about MALDI…
Pinch or no pinch, and how needle length changes the answer Replied, post #36 · Practice › Administration · 27 Aug 2025 · 2 likes Everything in post #35 holds. The case it does not cover is the one I have. If you have to inject at a different time of day than usual, that is a much smaller…
A request that was declined, and the reasoning — a second dataset Replied, post #21 · Documentation › Wiki requests · 7 Aug 2025 · 18 likes Where a request is for a translation or a regional version, the maintenance burden doubles and the proposal should say who carries it. One of those cases where knowing…
Sequence verification for an obscure compound: how it is done Replied, post #114 · Compounds › Other compounds · 3 Aug 2025 · 0 likes For any compound without a widely available reference standard, retention-time comparisons across laboratories are close to meaningless. Only a mass result travels.…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #41 · Clinical › Special populations · 15 Jul 2025 · 7 likes This is the sort of exchange that makes the archive worth searching.
Counter-ion content and its effect on measured mass Replied, post #84 · Analytics › Mass spectrometry · 6 Jul 2025 · 1 like I had written a reply contradicting post #80 and deleted it. Here is what survived. Mass accuracy is expressed in parts per million. It is the difference between…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #70 · Compounds › Retatrutide · 26 Jun 2025 · 0 likes Worth separating two things that post #68 runs together. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #35 · Practice › Dosing & titration · 18 Jun 2025 · 13 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
Why oral semaglutide needs an absorption enhancer at all Replied, post #12 · Compounds › Oral incretins · 15 Jun 2025 · 10 likes Where I have landed on oral semaglutide, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
A report I filed that turned out to be wrong, and the correction Replied, post #89 · Sourcing › Vendor reports · 6 Jun 2025 · 6 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
Coming back to: Getting a referral rather than a refusal Replied, post #29 · Clinical › Prescriber conversations · 3 Jun 2025 · 5 likes Narrowing post #26, because the general version has more than one answer. What I want from this Getting a referral thread is the list of things that would need to be…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #75 · Practice › Reconstitution · 22 May 2025 · 8 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Preparing for an appointment: one page, three questions Replied, post #17 · Clinical › Prescriber conversations · 3 May 2025 · 0 likes Helpful, and easy to find again, which is half of what a good reply is.
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #11 · Sourcing › Independent verification · 24 Apr 2025 · 20 likes The arithmetic in post #10 is right; the assumption feeding it is the part to check. Adding what did not work for me on Janoshik, since the failures never get written…
Carryover and the ghost peak from last week's standard Replied, post #17 · Analytics › HPLC & UHPLC · 3 Apr 2025 · 3 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
Retatrutide dose escalation in the published trials Replied, post #65 · Compounds › Retatrutide · 29 Mar 2025 · 0 likes This follows post #62 rather than contradicting it. Retatrutide dose escalation is a question about a distribution, not about a value, and treating it as a value is…
Coverage for the indication versus for the drug Replied, post #10 · Access › Insurance & coverage · 26 Mar 2025 · 0 likes Where I would push back on the coverage consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #113 · Compounds › Semaglutide · 23 Mar 2025 · 6 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
Follow-up: Individual participant data versus aggregate data Replied, post #26 · Evidence › Meta-analyses · 8 Jan 2025 · 32 likes On Individual participant data versus aggregate the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Why mass spectrometry cannot tell you about an epimer Replied, post #21 · Analytics › Mass spectrometry · 7 Jan 2025 · 0 likes Resolution: "high resolution" commonly means That distinction has done more work for me than anything else in this category.
When "no data" is the complete and final answer Replied, post #56 · Compounds › Other compounds · 2 Jan 2025 · 2 likes The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand accounts. Saying so is more useful than assembling the accounts into…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #104 · Compounds › Oral incretins · 28 Dec 2024 · 0 likes The gastrointestinal tolerability profile of the oral formulation is broadly similar in character to the injectable, which supports the effects being systemic rather…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #90 · Analytics › Method validation · 8 Dec 2024 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #54 · Compounds › Semaglutide · 1 Dec 2024 · 11 likes Narrowing post #53, because the general version has more than one answer. Research-use-only semaglutide is not a licensed medicine, is not manufactured to…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #78 · Clinical › Prescriber conversations · 19 Nov 2024 · 0 likes Post #75 answers the question as asked. The question underneath it is different. Discussing off-label dosing: if you want to dose differently than the label specifies…
When to suspect the method rather than the sample Replied, post #18 · Analytics › Method validation · 30 Sep 2024 · 0 likes The distinction between a qualified instrument and a validated method is worth keeping. Both are needed and they fail in different ways. The mechanism is plausible,…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #87 · Sourcing › Independent verification · 26 Sep 2024 · 15 likes Narrowing post #85, because the general version has more than one answer. Reframing Splitting a vial slightly, because I think the disagreement is about the question…
Irish differences from the UK position Replied, post #7 · Regional › UK & Ireland · 24 Sep 2024 · 3 likes Genuine question rather than a rhetorical one: has anyone here actually observed irish differences, as opposed to read about it? The thread is long and I cannot tell.
Second pass at: Retatrutide dose escalation in the published trials Replied, post #121 · Compounds › Retatrutide · 24 Jul 2024 · 15 likes Taking post #120 at face value and following it one step further. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide…
Cold packs, phase-change material, and what survives ten days Replied, post #100 · Sourcing › Logistics · 13 Jul 2024 · 17 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
Promotion criteria, and the one that stops most nominations Replied, post #12 · Documentation › Doc review · 4 Jul 2024 · 0 likes Useful. I have added it to my own notes with the date on it.